BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23142225)

  • 1. Elevated chemokine CC-motif receptor-like 2 (CCRL2) promotes cell migration and invasion in glioblastoma.
    Yin F; Xu Z; Wang Z; Yao H; Shen Z; Yu F; Tang Y; Fu D; Lin S; Lu G; Kung HF; Poon WS; Huang Y; Lin MC
    Biochem Biophys Res Commun; 2012 Dec; 429(3-4):168-72. PubMed ID: 23142225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.
    Wang LP; Cao J; Zhang J; Wang BY; Hu XC; Shao ZM; Wang ZH; Ou ZL
    Med Oncol; 2015 Nov; 32(11):254. PubMed ID: 26487662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis.
    Galligan CL; Matsuyama W; Matsukawa A; Mizuta H; Hodge DR; Howard OM; Yoshimura T
    Arthritis Rheum; 2004 Jun; 50(6):1806-14. PubMed ID: 15188357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of aquaporin-4 in the regulation of migration and invasion of human glioma cells.
    Ding T; Ma Y; Li W; Liu X; Ying G; Fu L; Gu F
    Int J Oncol; 2011 Jun; 38(6):1521-31. PubMed ID: 21424125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling.
    Li M; Ng SS; Wang J; Lai L; Leung SY; Franco M; Peng Y; He ML; Kung HF; Lin MC
    Cancer Res; 2006 Feb; 66(3):1583-90. PubMed ID: 16452216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1β microenvironment promotes proliferation, migration, and invasion of human glioma cells.
    Fathima Hurmath K; Ramaswamy P; Nandakumar DN
    Cell Biol Int; 2014 Dec; 38(12):1415-22. PubMed ID: 25053165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells.
    Monnier J; Lewén S; O'Hara E; Huang K; Tu H; Butcher EC; Zabel BA
    J Immunol; 2012 Jul; 189(2):956-67. PubMed ID: 22696441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.
    Miekus K; Kijowski J; Sekuła M; Majka M
    Oncol Rep; 2012 Nov; 28(5):1903-9. PubMed ID: 22941268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonredundant role of CCRL2 in lung dendritic cell trafficking.
    Otero K; Vecchi A; Hirsch E; Kearley J; Vermi W; Del Prete A; Gonzalvo-Feo S; Garlanda C; Azzolino O; Salogni L; Lloyd CM; Facchetti F; Mantovani A; Sozzani S
    Blood; 2010 Oct; 116(16):2942-9. PubMed ID: 20606167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells.
    Gessler F; Voss V; Dützmann S; Seifert V; Gerlach R; Kögel D
    Neuroscience; 2010 Feb; 165(4):1312-22. PubMed ID: 19958818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.
    Lemke D; Pfenning PN; Sahm F; Klein AC; Kempf T; Warnken U; Schnölzer M; Tudoran R; Weller M; Platten M; Wick W
    Clin Cancer Res; 2012 Jan; 18(1):105-17. PubMed ID: 22080438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.
    Yoshimura T; Oppenheim JJ
    Exp Cell Res; 2011 Mar; 317(5):674-84. PubMed ID: 21056554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma.
    Xu BJ; An QA; Srinivasa Gowda S; Yan W; Pierce LA; Abel TW; Rush SZ; Cooper MK; Ye F; Shyr Y; Weaver KD; Thompson RC
    Int J Oncol; 2012 Jun; 40(6):1995-2003. PubMed ID: 22307528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 in human glioma correlates with histopathological grade and cell migration.
    Yoshida T; Matsuda Y; Naito Z; Ishiwata T
    Pathol Int; 2012 Jul; 62(7):463-70. PubMed ID: 22726066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9.
    Kenig S; Alonso MB; Mueller MM; Lah TT
    Cancer Lett; 2010 Mar; 289(1):53-61. PubMed ID: 19700239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration.
    Farsam V; Basu A; Gatzka M; Treiber N; Schneider LA; Mulaw MA; Lucas T; Kochanek S; Dummer R; Levesque MP; Wlaschek M; Scharffetter-Kochanek K
    Oncotarget; 2016 Dec; 7(50):83554-83569. PubMed ID: 27907906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ephrin-B3 ligand promotes glioma invasion through activation of Rac1.
    Nakada M; Drake KL; Nakada S; Niska JA; Berens ME
    Cancer Res; 2006 Sep; 66(17):8492-500. PubMed ID: 16951161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
    Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
    Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells.
    Natarajan M; Stewart JE; Golemis EA; Pugacheva EN; Alexandropoulos K; Cox BD; Wang W; Grammer JR; Gladson CL
    Oncogene; 2006 Mar; 25(12):1721-32. PubMed ID: 16288224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.